NCL comments regarding Proposed Rule: Medication Guides: Patient Medication Information Docket No. FDA-2019-N-5959

November 21, 2023

Media contact: National Consumers League – Melody Merin,, 202-207-2831

The National Consumers League recently submitted comments regarding the Proposed Rule, Medication Guides: Patient Medication Information, that we believe will greatly improve the information patients receive with their prescription medicines.


About the National Consumers League (NCL)

The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit

The National Consumers League applauds Eli Lilly Decision to cap prices on insulin

March 6, 2023

Media contact: National Consumers League – Katie Brown,, 202-823-8442

Washington, D.C. – The National Consumers League commends the decision by drug company Eli Lilly to cut prices for insulin and cap costs insured patients pay to fill prescriptions.

“We applaud the Eli Lilly company for  taking steps to cap prices for insulin.  This action will provide much needed relief to patients suffering from diabetes who are currently facing steep annual costs for insulin, medicine that is life saving for those coping with their illness,” said NCL CEO Sally Greenberg.

The company said it will cut the list price for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% starting in October..

Lilly also said Wednesday that it will cut the price of its authorized generic version of Humalog to $25 a vial starting in May.

Lilly also is launching in April a biosimilar insulin to compete with Sanofi’s Lantus. NCL strongly supports the use of biosimilars as they introduce much needed competition and lower prices into the drug marketplace.

Lilly said people without insurance can find savings cards to receive insulin for the same amount at its website.

The federal government in January started applying that cap to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.


About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit

The National Consumers League sent a letter urging Senate Committee on Commerce, Science and Transportation to ensure that consumers get a fair deal at the pharmacy

February 21, 2023

Media contact: National Consumers League – Katie Brown,, 202-823-8442

Washington, D.C. – The National Consumers League (NCL) sent a letter urging Senate Committee on Commerce, Science and Transportation to ensure that consumers get a fair deal at the pharmacy. When it comes to the high out-of-pocket costs consumers face at the pharmacy counter — often for lifesaving medications — consumers today have an unfair disadvantage.

“With three PBMs controlling nearly 80 percent of all prescription drug claims, it is timely that lawmakers are looking at PBMs’ role in driving up the cost of drugs to consumers and patients,“ said Sally Greenberg NCL Chief Executive Officer. “We are encouraged to see the committee looking into the workings of PBMs and we are supportive of your efforts to hold these entities accountable.”

Beyond addressing the antitrust issues and increasing transparency of PBM revenue streams, we encouraged legislators to:

  • Remove medication barriers: PBMs should not be allowed to limit access to the medicines doctors prescribe.
  • Require PBMs to pass on savings directly to consumers: PBM rebates should be shared so that consumers can benefit from more affordable out-of-pocket costs. Additionally, patient cost-sharing should be based on the net cost of the drug, not the list price.
  • Ensure simple, single administrative PBM fees: PBMs too often tack on arbitrary fees to local pharmacies, with many independent and community pharmacies struggling to stay in business, this trickles down to the consumers, resulting in increased prices and pharmacy closures, leading to many communities facing pharmacy deserts.
  • Ensure PBM profits are not tied to the costs of medications: The system currently incentivizes PBMs to favor medicines with higher list prices so that they can negotiate larger rebates and/or steer patients to medicines with higher price tags to increase their own profits.

With the many evolving ways PBMs too often put profit over consumer interests, it is crucial that federal consumer protection agencies like the FTC have the tools needed to address the PBM problem.

To view the full letter, click here.


About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit

NCL’s Greenberg joins panel to discuss the challenges and opportunities of the generic and biosimilar industries

February 15, 2023

Media contact: National Consumers League – Katie Brown,, 202-823-8442

Washington, D.C. – NCL’s CEO Sally Greenberg spoke at the Association of Accessible Medicines and International Generic and Biosimilar Medicines Association Annual Meeting in Orlando, FL on Wednesday, February 15, 2023.

Greenberg joined the panel “The Generic and Biosimilar Industries Global Reputation” moderated by former NY Times journalist Gardiner Harris.

In her statements, Greenberg made the following points:

  • The generic and biosimilar industry has saved the US health care system an estimated $2.4 trillion between 2011 and 2020 and the industry is incredibly important to a well-functioning health care system.
  • NCL reinforces the messages with consumers that generic drugs contain the same active ingredients in the same dosages as brand name drugs, are every bit as safe and effective, but cost far less.
  • Biosimilars, developed after patents expire on brand name biologics, are as safe and effective as the original biologic, both brand biologics and biosimilars are rigorously and thoroughly evaluated by the FDA before approval and biosimilars have no clinically meaningful differences from the original biologic.
  • Over 90% of drugs are available in a generic version today, compared to less than 19% less than 4 decades ago, saving consumers and patients many millions of dollars each year.
  • The role of consumer advocacy groups like NCL will continue to be as an independent voice disseminating accurate, evidence based, scientifically grounded information about medicines and their safety and efficacy.

For the first time since 2014, the 25th International Generic and Biosimilar Medicines Association (IGBA) Annual Conference will be held in the United States, in conjunction with AAM’s Access! 2023 Annual Meeting. This event offers an opportunity to hear from leading global stakeholders, industry leaders, and other experts offering their views and analysis of the most pressing policy questions influencing patient access to generic and Biosimilar medicines in countries around the world.


About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit

The National Consumers League supports the bipartisan S 4918 (117th Congress) “Increasing Prescription Drug Competition Act”

February 7, 2023

Media contact: National Consumers League – Katie Brown,, 202-823-8442

Washington, D.C. – NCL is the nation’s oldest consumer and worker advocacy organization, formed in 1899 to work for a fair marketplace for all. NCL has long supported robust competition and affordable, accessible drugs for patients and consumers. We therefore appreciate the opportunity to provide our support for the bill introduced in the 117th Congress entitled “Increasing Prescription Drug Competition Act”, co-sponsored by Senator Maggie Hassan (D-NH) and Senator Mike Braun (R-IN). This legislation would bar the use of various loopholes in the law to block the introduction and sale of competitor drugs. One such familiar technique brand drug makers have used is claiming that a REMS programs (Risk Evaluation and Mitigation Strategies) required by the FDA for the brand version of the drug, prevents a competitor drug from entering the market. This argument goes against the prevailing view within the FDA and the FTC that a REMS requirement on the brand name drug must not be used as a way to block competition.

The Federal Trade Commission voted 4-0 to file an amicus brief  with the U.S. District Court for the District of Delaware on this topic.  The FTC brief takes no position on the scope or claim construction of the patent, but argues generally that there is significant harm to consumers when a brand lists a patent on a distribution system in the Food and Drug Administration’s “Orange Book” of approved drugs and thereby blocks the introduction of lower-cost generic medications or other follow-on competition. The FTC’s amicus brief explains how the Orange Book listing process can be abused, and emphasizes the harm to competition and consumers that can result from that abuse, including depriving consumers of potential competition from lower-cost alternatives and the ability to choose between products.

By way of background, we note these additional points:

  • REMS, or Risk Evaluation and Mitigation Strategies, are required by FDA for certain medications to ensure that the benefits of the drug outweigh its risks.  The sole purpose of a REMS is to protect patient safety
  • Despite policies that the former FDA Commissioner, Dr. Scott Gottlieb announced in 2018 to reduce the use of REMS programs as a way to block competition and access, followed by the CREATES act, which was signed into law in 2019, loopholes remain today
  • We look forward to the reintroduction of the bi-partisan bill proposed last fall by Senator Hassan (D-NH)and Senator Braun (R-IN), “Increasing Prescription Drug Competition Act”, which would no longer allow FDA approvals of medications to be delayed due to patents listed in the FDA “Orange Book” on REMS
  • We hope the legislation will address the problem of companies taking advantage of FDA-mandated safety programs at the expense of patients receiving innovative competitor medications, or generic medications. We believe that “Increasing Prescription Drug Competition Act”, bill will help to address that problem.


About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization.  Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad.  For more information, visit

2022 Script Your Future Medication Adherence Team Challenge Winners

The eleventh annual Script Your Future contest saw participation by 24 schools in 11 states and directly counseled nearly 7,000 patients nationwide

Media contact: National Consumers League – Katie Brown,, (202) 207-2832

May 13, 2022

Washington, DC —Today, the National Consumers League (NCL) and its partners announced the winners of the eleventh annual Script Your Future Medication Adherence Team Challenge, a competition designed to engage pharmacy students and faculty across the nation by encouraging teams to develop creative initiatives to raise public awareness about the importance of medication adherence, vaccine confidence, and safe drug disposal.

This year’s winners are Wilkes University, Temple University, Western University, Northeast Ohio Medical University (NEOMED), University of Pittsburgh, and Touro University California.

The 2022 Script Your Future Team Challenge is an awareness campaign coordinated by NCL with support from its partners and the Challenge sponsors—Eli Lilly, Deterra, the American Association of Colleges of Pharmacy (AACP), the American Pharmacists Association (APhA), and the National Community Pharmacists Association (NCPA).

The Team Challenge was first established in 2011 to nurture adherence-minded values in future generations of professionals entering the workplace.

In 2022, our Team Challenge student health professionals spread messaging on the importance of medication adherence, vaccine confidence, and a new health topic: safe drug disposal. This year, over 1,000 future healthcare professionals and volunteers from across 11 states participated in the Team Challenge.

2021 Medication Adherence Team Challenge Winners

This year’s winners, selected from dozens of applications and 24 participating educational institutions, are listed below.

National Award Winner: Wilkes University Nesbitt School of Pharmacy – PA

Wilkes University is a fourth-time participant of the Script Your Future Team Challenge, and a first-time winner of the National Award! During the 2022 Team Challenge, students on the Wilkes team successfully collaborated with Highmark Health pharmacists to create a medication adherence questionnaire that was circulated to patients. They also creatively used social media, including TikTok and YouTube, to spread messages about the importance of medication adherence, vaccine confidence, and safe drug disposal. These messages got over 58,000 views. Students were also able to vaccinate patients for COVID-19 (boosters), Shingles, and Influenza. The Wilkes team was able to directly counsel 1,184 patients, and reached 49,313 people through their outreach efforts.


National Award Winner: Temple University School of Pharmacy – PA

Temple University is also a first-time winner of the Script Your Future National Award! This year, Temple students of pharmacy collaborated with health and community organizations in Philadelphia, including Temple University Hospital, and its affiliated clinics as well as the places where people live their lives such as local community pharmacies, parks, churches, charitable organizations, and schools. For example, Temple’s team worked with Dispose Rx to spread messages about the importance of safe drug disposal in North Philadelphia. This team also worked with the Children’s Mission to serve people who have no or unstable housing, and counseled them on their medications along with conducting blood pressure checks. Temple students directly counseled 234 patients, and reached over 400 patients through their activities.


Health Disparities/Underserved Focus Award Winner: Northeast Ohio Medical University School of Pharmacy – OH

The Northeast Ohio Medical University School of Pharmacy (NEOMED) team is this year’s winner of the Script Your Future Health Disparities Award! NEOMED’s team focused on reaching low-income and homeless individuals, the elderly, and refugees. NEOMED students worked with the Center for Families and Children, IKON Health Foundation, and Rose Centers for Aging Well to reach these underserved populations. Through their efforts, the NEOMED team vaccinated 456 patients, directly counseled 1,323 patients, reached 1,923 patients, and distributed and donated 3,254 resources.


Media Outreach Award Winner: Western University School of Health Sciences, College of Pharmacy – CA

This year’s winner of the Media Outreach Award is Western University College of Pharmacy! This team implemented creative uses of traditional and social media to spread messaging related to medication adherence, vaccine confidence, cardiovascular disease, diabetes, interprofessional collaboration, antimicrobial resistance, and safe drug storage & disposal. They created a brand-new podcast series that aimed to provide information on these topics, and made them available on multiple media platforms including Spotify, Apple Podcasts, Google Podcasts, and their website. The podcast series can be found here. Across all of these platforms, Western University’s team was able to get 1,203 views.


Creative Interprofessional Team Event Award Winner: University of Pittsburgh School of Pharmacy – PA

University of Pittsburgh’s pharmacy students demonstrated great interprofessional collaborations with other health professional students at their university. Their team included students from the University of Pittsburgh’s School of Dental Medicine, School of Health and Rehabilitation Sciences, School of Medicine, School of Nursing, and School of Social Work. Their multi-disciplinary intervention with different health professional students helped to bring multiple perspectives and skills sets together to bridge gaps in expertise when counseling patients. Their interprofessional team documented over 1,800 unique patient encounters at community pharmacy sites, including patients with disease states like hypertension, diabetes, and dyslipidemia to transplant and neurologic disorders.


Technology Innovation Focused Award: Touro University California, College of Pharmacy – CA

Touro University’s pharmacy students implemented creative uses of technology to increase messaging for medication adherence. They created a digital medication adherence wallet card, to help patients keep track of their medications in a more convenient way. Given that technology is so widely used today, this was a great effort by the students. They did mention an important issue, that there are people who do not have internet access, so these digital cards were given in complement with the physical wallet cards.

2022 School

Congratulations to the winners of the 2022 Script Your Future Medication Adherence Team Challenge!


A word from NCL and one of our generous Script Your Future sponsors

“The Script Your Future program has been a great way to engage future health professionals and spread messages about the importance of medication adherence, vaccine confidence, and now, safe drug disposal. As we are still combatting the COVID-19 pandemic, it is important to keep patients on top of their health care needs, and participants of this program have been a part of these efforts. This year, we had over 1,000 participants conduct community outreach activities, and NCL continues to be impressed by the impact these students have on their respective communities across the country.”

  • NCL Executive Director, Sally Greenberg


Student pharmacists have been important contributors to the outreach to communities, especially throughout the pandemic. Medication adherence, vaccine access, and substance use prevention are critically important priorities and AACP appreciates NCL’s commitment to this recognition program.

  • American Association of Colleges of Pharmacy (AACP) Executive Vice President and CEO, Lucinda L. Maine, PhD, RPh


About the National Consumers League (NCL) 

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit


NCL applauds USP for new and revised compounding standards

Every day, thousands of consumers in the United States—including those with rare diseases or allergies to commercially available drugs—rely on specially and individually made medicines known as compounded drugs. Compounding is critically important for patients but, if done improperly, this process can pose significant risks to patients and healthcare workers alike. Patients could—and have—received contaminated drugs or preparations that are subpotent, contaminated, or super-potent. Healthcare workers, in turn, can face risks of exposure to hazardous drugs.

A stark example is the 2012 series of medical errors that resulted in the contamination of compounded medicines, which in turn caused a deadly fungal meningitis outbreak in the United States—killing more than 70 people and causing more than 750 cases of infection in 20 states.

To reduce these public health risks, Congress and other policymakers have swung into action. Today, compounding requires universal standards that advance public health and patient safety priorities. A key player in this is the United States Pharmacopeia (USP), a scientific non-governmental standards-setting organization, which recently published new and revised compounding standards to help produce consistent quality compounded medicines and ensure that patients receive medicines that are the right strength, quality, and free of contaminants.

These updated standards reflect the latest advancements in science and clinical practice, and incorporate input from thousands of stakeholders in the medical and public health community—patients, healthcare practitioners, policymakers, academicians, and industry. The standards complement robust implementation of existing laws intended to ensure quality compounded products with the goal of protecting the safety of patients.

Consumers have an important role to play as we roll out the new guidelines for quality compounding and implementation of the new USP standards:

  • If you receive compounded medicines through your pharmacist or healthcare provider, report any resulting adverse events to your healthcare provider.
  • Sign up for FDA email alerts on safe compounding.
  • Remember to always contact your healthcare provider if you have questions or concerns about your health.

NCL is encouraged to see that the revised USP standards are consistent with FDA guidances. We applaud the efforts of FDA and USP to collaborate with the public health community to help protect patient safety.

Knowledge is power: What consumers need to know about safe use of pain treatments – National Consumers League

Sally GreenbergThe National Consumers League has long worked to inform consumers about the safe use of medication. Sadly, today many American communities are struggling with an epidemic: the misuse of prescription opioids, which seems to know no socioeconomic or demographic bounds. In 2016, more than 11 million people misused prescription opioids in the United States, and the latest data show that 115 Americans die each day from an opioid overdose.

The explosion of opioid abuse has complicated roots, but among them is the mistake of keeping unused prescriptions in the medicine cabinet long after they are prescribed. In that vein, NCL recommends specific steps consumers, families, and the public can take to mitigate the chances of opioid abuse.

Since as many as one in four people prescribed opioids long term struggle with addiction, the conversation about treatment and safe use must start before a medicine is prescribed.

Consumers should engage their healthcare provider and/or pharmacist before they take home a prescription opioid.

Be prepared ahead of medical appointments or surgery.

We have all walked out of a doctor’s office failing to ask important questions. Before your next doctor’s appointment, write down all your questions ahead of time and include an updated list of the medications you are taking. If you are prescribed a painkiller, ask about safe use and ask whether it’s habit forming. Some drugs are, while some are not.

Understand the risks and benefits of any new medicine.

If opioids are truly needed to manage pain, understand the potential benefits, risks, and side effects associated with them.

Here are a few questions to ask your healthcare provider when prescribed a new medicine:

  • What side effects should I expect and what should I do about them?
  • Will this medicine interact with any other medicines I am taking?
  • How should I safely store this medicine?

We recommend checking out the National Council on Patient Information and Education’s Talk Before You Take website.

Ask about partial-fill options.

When prescribed a prescription painkiller, consider asking to only partially fill your prescription, an option available in some states. If you need to fill the rest of the prescription, you can pick up the remaining dose at the pharmacy.

Use opioids only as prescribed — do not share your prescription.  

About 40 percent of those who misused prescription opioids in the past year said they obtained the medicine from a family member or friend for free, according to a national survey.  That’s a problem; opioids should only be taken as prescribed by your healthcare provider and stored in a secure place.  

Immediately dispose of unused pills.

As noted in my December blog post, disposal of unused prescription medications is critical.  Allied Against Opioid Abuse has compiled a list of national and state resources to assist you.

Consumers using the strategies outlined here have gone a long way toward reducing the chance of opioid abuse and misuse, which is one of the country’s biggest public health challenges.

Knowing your rights, risks, and responsibilities with prescription opioids can help all of us prevent abuse and misuse before it occurs.

From patient To consumer: Reimagining health care from a consumer perspective – National Consumers League

family-on-bikes.jpgThe following Huffington Post op-ed was published August 18, co-authored by NCL’s Sally Greenberg and Marilyn Tavenner, the President and CEO of America’s Health Insurance Plans.

Navigating our health care system is no easy task. For decades, consumers have been forced to contend with a fragmented health system that makes decision making an all-consuming challenge. Whether it’s choosing a provider, knowing where to get information about cost or quality of doctors, or understanding a dictionary of complex health care terms, many consumers often feel left to fend for themselves in a system that is working against them.

For many individuals, it’s hard to know where to start. A recent state analysis by Rice University in Texas found that 42 percent of consumers who bought their own insurance felt like they lacked a clear understanding of their health insurance plans. Nearly a quarter of those surveyed who had employer-sponsored coverage still struggled with understanding their benefits.

We need to find a way to change this. While we all recognize the seismic shift underway as the age of consumerism in health care finally takes hold, we have to ask ourselves if we are truly practicing what we preach. We all have a responsibility to provide consumers with the transparent, actionable information they need to make smart choices about their care.

The good news is that online and mobile apps are making it increasingly easy for consumers to access information on their own time and with relative simplicity. Health plans have rolled out provider cost and quality calculators, and websites like FAIR Health make it possible for patients to see what a typical doctor’s visit or MRI will cost before they even walk into a provider’s office.

But even with this push towards more available data, we know that individuals and families still struggle when it comes to understanding and using their insurance benefits. Commonly searched online terms around insurance include, “what are deductibles?”, “finding a doctor,” and “how much will I pay in premiums?” Consumers are clearly telegraphing the need for simple, easy-to-understand information about their coverage.

Recently, our two organizations came together to compare notes on how we could collaborate to improve consumers’ health care experience. As a first step, we agreed that while there is a wealth of information in the market available for consumers, it is often poorly organized, out-of-date, or like the health care system itself, requires consumers to search multiple places for the information they need. Our first joint project will bring critical information together and present it in ways that are useful for consumers. We will rely on AHIP’s considerable knowledge of health insurance and NCL’s more than 100 years of consumer education to make information accessible, understandable, and actionable.

Our work builds upon what we have learned over the past several years on the frontlines of this health care transformation. A recent report from McKinsey found that although consumers are beginning to research their health plan choices, many of them are not yet aware of key factors they should consider before selecting coverage, such as the type of health plan and provider network, level of coverage, premiums, cost-sharing, covered services, drug formularies and tiers, and health status and anticipated utilization. Even once they have their insurance plan, many consumers may not be aware of all the benefits that are included, including free preventive services, disease management programs, fitness plans – and equally important, the tools they have available to get the best value for their health care dollars.

As consumers prepare for the upcoming open enrollment periods for Medicare and the Exchanges, AHIP and NCL will share new consumer resources and information answering some of the important questions about insurance coverage and health care ranging from how to choose a health plan to how to choose a doctor, as well as consumers’ rights if they feel they’ve been inappropriately denied a product or service that should be covered by their plan.

We know that health care isn’t always simple, but if we are to be successful in moving towards a patient-centered health system, we have to start by making health care information more accessible and usable for consumers. While this partnership is a first step, our hope is that our combined efforts will encourage and support the important work underway to improve consumers’ experience with the health system and the wellbeing of the country as a whole.

This article originally appeared in the Huffington Post.

So Simple, So Hard tackles adherence challenges in CA – National Consumers League

“So Simple, So Hard” was the theme of the medication adherence conference the National Consumers League (NCL) held on September 15 in Sacramento, California. Sponsored by the Agency for Healthcare Research and Quality (AHRQ), the speakers and attendees explored the challenges and barriers to medication adherence – why it is so hard – and highlighted the tools and strategies to make it simpler and to improve adherence and health outcomes, especially among underserved populations.

NCL gathered more than 80 stakeholders in Sacramento, including health care professionals, community health workers, advocates, industry representatives, policymakers, and researchers. Throughout the day, conference participants heard from researchers and experts on adherence, and engaged with each other about possible collaborations and solutions.

The meeting kicked off with presentations on adherence research and health disparities, and continued with a variety of strategies and tools to improve adherence that could be utilized in health care practices or organizations. Takeaways from the presentations included the following:

  • One size does not fit all – adherence intervention work best when tailored for the patient
  • Quality of communication and a sense of collaboration between patients and health care professionals impact adherence, especially among people of color   
  • Adherence rates are unique to each medication a patient takes 
  • Cultural considerations are vital to understanding barriers to adherence
  • Always consider the health literacy of the patient
  • Determining the reasons for poor adherence is essential to developing effective interventions   

Specific strategies and solutions:

  • Medication synchronization
  • Comprehensive medication review
  • Tools for translating medication labels into the patient’s native language
  • Best practices and tools for more culturally competent clinical care

The conference provided a forum for participants to interact, connect, and lay the groundwork to develop partnerships for collaborative initiatives. We will be following up with all conference participants to determine the benefits of the conference and learn of any connections and /or collaborations developed.  

At NCL, we view poor adherence, with its devastating effect on health outcomes, as a public health problem. Since 2011, we have been leading Script Your Future – a public education campaign to increase awareness among patients, their family caregivers, and health care professionals of the importance of taking medication as directed.

As leaders of Script Your Future, NCL convened an AHRQ research dissemination conference to further explore possible solutions to this public health problem. The adherence issue is complex and taking medications is NOT so simple, especially for ethnic and racial minorities who often face health disparities. Collaboration among stakeholders who are dedicated to keeping the patient at the center of the discussion, is a critical first step toward developing and implementing effective medication adherence strategies to help people better self-manage their care.  

Conference participants and others are encouraged to distribute information from the conference to interested colleagues and through their networks. We look forward to hearing how others are sharing the information, tools, and resources from the conference, and the possible collaborations that will grow out of the meeting.   

* Funding for this conference was made possible in part by grant number 1R13HS023948-01A1 from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government